Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies
Analgesic Effect of Combination of Superior Hypogastric Plexus Block and Transversus Abdominis Plane Block in Abdominal Hysterectomies: A Randomized Controlled Trial
研究概览
地位
详细说明
Abdominal hysterectomy is a major surgery that is often associated with pronounced postsurgical pain. Inadequate postoperative analgesia can lead to postoperative complications and can delay functional recovery. Accordingly, a multimodal regimen for postoperative pain management is recommended.
The transverse abdominis plane (TAP) block is a regional block anesthetizing the nerves (T10 to L1) hence covering the lower abdominal wall.
The superior hypogastric plexus (SHP), which lies retroperitoneally in front of the L5 and S1 vertebrae, provides innervation to the pelvic viscera. The blockade of SHP is well-recognized for the management of chronic pelvic pain.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Mohammed S Elsharkawy, MD
- 电话号码:00201148207870
- 邮箱:mselsharkawy@med.tanta.edu.eg
学习地点
-
-
El-Gharbia
-
Tanta、El-Gharbia、埃及、31527
- 招聘中
- Tanta University
-
接触:
- Mohammed S Elsharkawy, MD
- 电话号码:00201148207870
- 邮箱:mselsharkawy@med.tanta.edu.eg
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age ≥ 18 years.
- American Society of Anesthesiology (ASA) physical status I-II.
- Undergoing abdominal hysterectomies under general anesthesia (GA).
Exclusion Criteria:
- History of allergies to local anesthetics.
- Body mass index (BMI) >35 kg/m2.
- Opioid dependency.
- Cognitive impairment.
- Bleeding or coagulation disorders.
- Psychiatric and neurological disorder.
- Local infection at the site of injection.
- Severe heart, lung, liver, and renal dysfunction.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group S
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of bupivacaine 0.25%+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
|
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of bupivacaine 0.25%+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
|
|
有源比较器:Group C
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of saline 0.9% (sham)+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
|
Patients will receive superior hypogastric plexus block (SHPB) using 20ml of saline 0.9% (sham)+ transverse abdominis plane (TAP) block using 20ml of bupivacaine 0.25%.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Time to the first request for the rescue analgesia
大体时间:24 hours postoperatively
|
Time to the first request for the rescue analgesia will be recorded from the end of surgery to first dose of morphine administrated.
|
24 hours postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
总吗啡消耗
大体时间:术后24小时
|
如果数字额定量表(NRS)> 3在30分钟后重复,则如果疼痛持续到NRS <4,则吗啡的救援镇痛为3 mg推注。
|
术后24小时
|
|
痛苦程度
大体时间:术后24小时
|
将指示每个患者使用数字评分量表(NRS)进行术后疼痛评估。
NRS(0代表“无疼痛”,而10代表“可以想象的最严重的疼痛”)。
NRS将在术后2、4、6、8、12、18和24小时的麻醉后护理单位(PACU)进行评估。
|
术后24小时
|
|
不良事件发生率
大体时间:术后24小时
|
将记录不良反应的发生率,例如心动过缓、低血压、恶心、呕吐、呼吸抑制、瘙痒或任何其他并发症。
|
术后24小时
|
|
Quality of recovery
大体时间:24 hours postoperatively
|
The quality of recovery (QoR-15) score will be assessed 24 hours postoperatively.
This tool consists of 15 questions, each scored on a 10-point scale, yielding a maximum of 150.
It encompasses five domains; physical comfort (questions 1-4, 13), emotional state (questions 9, 10, 14, 15), psychological support (questions 6, 7), physical independence (questions 5, 8), and pain (questions 11, 12).
|
24 hours postoperatively
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 36265PR2/4/26
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.